November 7th, 2022

New University Hospital Research Chair in Pain Management


Towards more effective and safe pain treatments than opioids?

Prof. Louis Gendron
Research Chair in Pain Management and Opioid Pharmacology

If you were one of the 8 million people in Canada who suffer from chronic pain in their lifetime, you would want a drug that has strong analgesic power but does not have overwhelming side effects or addiction. That molecule doesn't exist yet, but the new Chair in Pain Management and Opioid Pharmacology, led by Louis Gendron, expects to make significant progress in this area.

Opioids such as morphine are still among the most effective medications for treating moderate to severe pain, but they carry with them inconveniences and even health risks: nausea, constipation, respiratory depression and psychological dependence. In addition, in about 35% of people, opioid painkillers simply don't work.

For researchers like Louis Gendron, there is no question of leaving patients to their fate. Over the next five years, he will use his expertise to improve their quality of life by developing new strategies and therapies for the treatment of pain using opioid receptors as pharmacological targets.

The work is divided into two areas: the treatment of chronic pain, to develop new drugs with fewer side effects but with good pain relief; and providing alternatives that will not contribute to the opioid crisis.

Professor Louis Gendron, Chair

His multidisciplinary research program will focus on the delta opioid receptor, which has significant analgesic potential with minimal adverse effects. As an added bonus, delta antagonists are less likely to be abused and addicted.

The Chair was created thanks to philanthropic contributions from the Fondation du Centre hospitalier universitaire de Sherbrooke (CHUS), the Centre de recherche du CHUS and the Faculty of Medicine and Health Sciences. The value of these contributions now totals $1 million.

It's important for us to offer our patients the best treatments here in the region. Research is eventually transferred to care, and that's why we invest.

Martin Clermont, Executive Director, Fondation du CHUS

Training the next generation of scientists in the fields of pain, opioids and molecular pharmacology is an important part of this research chair. "We will offer scholarships to graduate students to continue their studies in my laboratory," says Prof. Gendron.

Other news

See all news
Josée and Mathilde during a visit to CIUSSS de l'Estrie - CHUS.


February 13, 2024
News from Mathilde

A year ago, we met Josée, the mother of Mathilde, who suffers from epilepsy and receives treatment here in Sherbrooke. On this International Epilepsy Day, we asked Josée for an update on her daughter.

Employees and Foundation staff on the phone on Thank You Day.


January 11, 2024
Many thanks

The hearts of all CHUS Foundation employees overflowed with gratitude last Thursday as we celebrated World Thank You Day.

Romeo Ambiance product for entreprise Papillon


December 19, 2023
When a story inspires you to give back

Year after year, the CHUS Foundation is fortunate to see new companies join the Papillon corporate movement, making donations through the sale of certain products or through a collection at the cash register.

New positron emission tomography (PET-CT) scanners presented at CRCHUS


November 2, 2023
New devices that make a big difference for patients!

The acquisition of three new positron emission tomography (PET-CT) scanners has enabled us to carry out more clinical examinations in the past year and advance research into type 2 diabetes.

2022-2023 Impact report


October 2023
Together, we go further!

You give us wings!

Laurie & Charlie
2023 annual campaign CHUS Foundation


June 20, 2023
We keep a close eye on your health.

Do you know why we need you? To bring the best care to local people, close to home.

End of the CHUS Foundation's major fundraising campaign - 2018-2022


May 3rd, 2023
Major campaign of the CHUS Foundation: a record amount to be reinvested in health

It is with immense pride that the CHUS Foundation announces that it has raised a record $48,617,950 during its major campaign, which began in 2018 and just ended in March.

Photo at the Phoenix in Sherbrooke


November 27th, 2022
Success for the CHUS Foundation match!

The Fondation du CHUS game ends particularly well: a Phoenix victory and $6,590 for children treated in pediatric oncology!

Photo boxers Laiterie de Coaticook


November 23rd, 2022
The CHUS Foundation and the Laiterie de Coaticook join forces for health

A brand new fundraising campaign for the Fondation du CHUS has just been launched thanks to the Laiterie de Coaticook!

Isabelle, head of the operating block department


June 28th, 2022
CHUS Foundation seeks donors for new operating room

The CHUS Foundation calls upon donors to fund a new state-of-the-art integrated operating room at the Fleurimont Hospital of the CIUSSS de l’Estrie – CHUS.

Two men talking to each other while hanging letters on a building


April 5, 2022
The CHUS Foundation Makes a Huge Difference with Small Donations

The CHUS Foundation launched an advertising campaign this week to promote the final wave of its 2018-2022 major fundraising campaign.

CHUS Foundation logo


March 28, 2022
The CHUS Foundation Modernizes its Brand Image

In March 2022, after a 10-year run for the previous logo, the CHUS Foundation launched a new branding which is more current, modern, and reflective of its image.

Portrait of Dr Claudio Jeldres, urologist and project leader, and researchers Martin Bisaillon and François-Michel Boisvert in their laboratory.


February 1, 2022
The CHUS Foundation Funds Research Project on Bladder Cancer

The CHUS Foundation announces $470,000 for bladder cancer research.

two hands holding each other


November 19, 2022
More than $5.5 Million Raised by the CHUS Foundation

Tonight was the 10th edition of the CHUS Foundation' annual Au cœur de la vie program, in collaboration with Radio-Canada. The donations collected during the evening were the high point of the annual fundraising campaign, bringing the total to $5,537,803.